FLT3 and acute myeloid leukemia: Considering that FLT3 and FLT3 mutants have been significantly associated with FLT3 mutant-mediated AML, compound 7d could be a valuable molecule for FLT3-mutant positive physiology and pathology research and a potential therapeutic agent.